213 related articles for article (PubMed ID: 21556345)
21. Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model.
Shao W; Paul A; Zhao B; Lee C; Rodes L; Prakash S
Biomaterials; 2013 Dec; 34(38):10109-19. PubMed ID: 24060420
[TBL] [Abstract][Full Text] [Related]
22. Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation.
Zhao Y; Cai C; Liu M; Zhao Y; Wu Y; Fan Z; Ding Z; Zhang H; Wang Z; Han J
Int J Biol Macromol; 2020 Jun; 153():873-882. PubMed ID: 32169451
[TBL] [Abstract][Full Text] [Related]
23. Novel free paclitaxel-loaded poly(L-γ-glutamylglutamine)-paclitaxel nanoparticles.
Yang D; Van S; Jiang X; Yu L
Int J Nanomedicine; 2011 Jan; 6():85-91. PubMed ID: 21289985
[TBL] [Abstract][Full Text] [Related]
24. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
[No Abstract] [Full Text] [Related]
25. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
[TBL] [Abstract][Full Text] [Related]
26. Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications.
Chun C; Lee SM; Kim SY; Yang HK; Song SC
Biomaterials; 2009 Apr; 30(12):2349-60. PubMed ID: 19178941
[TBL] [Abstract][Full Text] [Related]
27. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.
Wang L; Jia E
Drug Deliv; 2016 Jun; 23(5):1810-7. PubMed ID: 26530693
[TBL] [Abstract][Full Text] [Related]
28. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
[TBL] [Abstract][Full Text] [Related]
29. Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood-brain barrier in vitro and in vivo.
Kafa H; Wang JT; Rubio N; Klippstein R; Costa PM; Hassan HA; Sosabowski JK; Bansal SS; Preston JE; Abbott NJ; Al-Jamal KT
J Control Release; 2016 Mar; 225():217-29. PubMed ID: 26809004
[TBL] [Abstract][Full Text] [Related]
30. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
[TBL] [Abstract][Full Text] [Related]
31. Controlled release of paclitaxel from a self-assembling peptide hydrogel formed in situ and antitumor study in vitro.
Liu J; Zhang L; Yang Z; Zhao X
Int J Nanomedicine; 2011; 6():2143-53. PubMed ID: 22114478
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
[TBL] [Abstract][Full Text] [Related]
33. Supramolecular assembly and antitumor activity of multiwalled carbon nanotube-camptothecin complexes.
Tian Z; Yin M; Ma H; Zhu L; Shen H; Jia N
J Nanosci Nanotechnol; 2011 Feb; 11(2):953-8. PubMed ID: 21456124
[TBL] [Abstract][Full Text] [Related]
34. Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate.
Lv Q; Yang J; Zhang R; Yang Z; Yang Z; Wang Y; Xu Y; He Z
Mol Pharm; 2018 May; 15(5):1842-1852. PubMed ID: 29608845
[TBL] [Abstract][Full Text] [Related]
35. Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study.
Eldar-Boock A; Blau R; Ryppa C; Baabur-Cohen H; Many A; Vicent MJ; Kratz F; Sanchis J; Satchi-Fainaro R
J Drug Target; 2017; 25(9-10):829-844. PubMed ID: 28737432
[TBL] [Abstract][Full Text] [Related]
36. Coloaded Nanoparticles of Paclitaxel and Piperlongumine for Enhancing Synergistic Antitumor Activities and Reducing Toxicity.
Liu Q; Zhao D; Zhu X; Chen H; Yang Y; Xu J; Zhang Q; Fan A; Li N; Guo C; Kong Y; Lu Y; Chen X
J Pharm Sci; 2017 Oct; 106(10):3066-3075. PubMed ID: 28552690
[TBL] [Abstract][Full Text] [Related]
37. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.
Huang X; Zhang Y; Yin G; Pu X; Liao X; Huang Z; Chen X; Yao Y
J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516
[TBL] [Abstract][Full Text] [Related]
38. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.
Sahu PK; Mishra DK; Jain N; Rajoriya V; Jain AK
Drug Dev Ind Pharm; 2015 Apr; 41(4):640-9. PubMed ID: 24564799
[TBL] [Abstract][Full Text] [Related]
39. Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier.
Xu Z; Zhu S; Wang M; Li Y; Shi P; Huang X
ACS Appl Mater Interfaces; 2015 Jan; 7(2):1355-63. PubMed ID: 25546399
[TBL] [Abstract][Full Text] [Related]
40. Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation.
Dosio F; Reddy LH; Ferrero A; Stella B; Cattel L; Couvreur P
Bioconjug Chem; 2010 Jul; 21(7):1349-61. PubMed ID: 20597546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
